Induction of hepatic drug metabolizing enzymes by DL-methionine in rats.

A single intraperitoneal injection of DL-methionine (500 mg/kg body wt.) to adult male Wistar rats was shown to significantly induce all the components of the hepatic microsomal mixed function oxidase system such as NADPH cytochrome C reductase activity, cytochromes P-450 and b5, as well as activities of drug metabolizing enzymes such as aminopyrine demethylase and uridine 5'-diphosphate-glucuronosyltransferase. Combined administration of nicotinamide (250 mg/kg body wt.) and DL-methionine (500 mg/kg body wt.) was shown to bring about an additional increase (25-30%) in the activities of these enzymes as compared to their induction on independent administration of the two endobiotics. In rats bearing Yoshida sarcoma (ascites) tumour as well as in normal rats injected with serum from tumour bearing animals, the decreased activities of hepatic mixed function oxidases could be restored to their normal levels by administration of DLmethionine (500 mg/kg body wt.) to these rats. Whereas actinomycin D (1 mg/kg body wt.) had no effect on the increased incorporation of [14C] labelled leucine into microsomal proteins following administration of nicotinamide, the enhanced incorporation of the label following DL-methionine administration was completely inhibited by the same dose of actinomycin D. Administration of cycloheximide (0·5 mg/kg body wt.) to rats could completely inhibit the increased incorporation of [14C] leucine into hepatic microsomal proteins following independent administration of nicotinamide and DL-methionine. Similar inhibitory pattern with actinomycin D and cycloheximide was also demonstrated in case of induction of NADPH cytochrome C reductase activity by both these endobiotics.

Transfer RNA methylases and carcinogenesis.

An increased tRNA methylase activity (100 %) accompanied by a 40 % decrease in the regulatory glycine methyltransferase activity was demonstrated in livers of mice fed on the carcinogenic (thioacetamide) diet, long before the onset of malignant transformation. Shortterm treatment with thioacetamide and phenobarbital independently, also brought about a significant increase in the rat liver tRNA methylase activity. A significant increase in the tRNA methylase activity was observed in the mammary glands of pregnant as well as lactating mice as against the negligible enzyme activity in the normal mammary glands of C3H and CBA mice, whereas a large increase in the tRNA methylase activity was evident in the spontaneously induced mammary tumours in these strains. Hepatic tRNA methylase activity was shown to remain unaffected in rats during various physiological stress conditions. It is suggested that elevation in the tRNA methylase activity may be one of the prerequisites during malignant transformation. A considerable increase in the tRNA methylase activity in host tissues of the tumour-bearing mice was also demonstrated.